How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Allotera Therapeutics Announces Opening of Minimal Residual Disease Cohort in the Pivotal T-RRex Study of Sofi-cel

calendar_today September 23, 2026 person errol domain wugen

The minimal residual disease-positive cohort opens as part of the pivotal-stage development of Soficabtagene Geleucel (Sofi-cel), an off-the-shelf CAR-T cell […]

open_in_new Read original post